WinstonDunnMD
Gastroenterology • Kansas City, KSHepatology & Liver Transplantation
Assistant Professor, Internal Medicine, University Kansas School of Medicine
Dr. Dunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
# Wescoe
Kansas City, KS 66160Phone+1 507-284-2511Fax+1 913-588-3975
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2009 - 2010
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2006 - 2009- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003
Certifications & Licensure
CA State Medical License 2005 - Present
KS State Medical License 2010 - 2025
MO State Medical License 2021 - 2025
MN State Medical License 2009 - 2011- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 374 citationsMELD accurately predicts mortality in patients with alcoholic hepatitisWinston Dunn, Laith H. Jamil, Larry S. Brown, Russell H. Wiesner, W. Ray Kim
Hepatology. 2005-02-01 - 53 citationsIdentification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.Juan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, Francisco Idalsoaga, Eduardo Fuentes-López
Journal of Hepatology. 2021-11-01 - 200 citationsModest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)Winston Dunn, Arun J. Sanyal, Elizabeth M. Brunt, Aynur Unalp-Arida, Michael C. Donohue
Journal of Hepatology. 2012-08-01
Press Mentions
Gene Predicts Recovery from Decompensated HCV CirrhosisApril 10th, 2019
Study: Genetic Markers May Predict Which HCV, Cirrhosis Patients Improve with TreatmentMay 6th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
